15 March 2018

My name is Paola de Haas, I am Dutch and I am a PhD candidate in the department of Cell Biology in the theme Nanomedicine.

When you were a kid what did you want to be when you grew up? Can you tell us something about your child years. 

When I was a kid I wanted to be all kinds of different things when I grew up. When I was very little I wanted to become a mailman, because I thought that I would always know the way and never get lost. Later on it changed into a vet because I would really enjoy working with animals. Then at some point I changed the animals for humans and I wanted to become a medical doctor. This idea stuck with me until I started studying Medical Biology and I realized a career in research suited me much better.

What was your previous academic training, where did you study and why that study? 

I studied Medical Biology at the Radboud University. Biology was always my favourite subject, I was interested in the way things worked. Even though I also really enjoyed plant and animal related courses, my main interests were still related to the human body in health and disease.

The RIMLS motto is “Today’s molecules for tomorrow’s medicine”. What does this mean for you? 

The research I do is quite strongly related to patients and is aimed at trying to understand the molecular basis of their disease and symptoms. I am studying a subtype of the congenital disorders of glycosylation (CDG) in which patients have an impaired N-glycosylation. I think in this study molecules can not only help to gain knowledge about the disease but in addition looking at the patient phenotype can help us understand something about the role of molecules, N-glycans in my case.

Who is your great example as scientists? And please give a motivation why.

That is a difficult one! I think I would choose Jonas Salk, who developed the first successful vaccine against polio. He volunteered himself to take part in the clinical trial to test the vaccine. When the vaccine became available for everyone he did not patent it because he thought it belonged to the people. I think that shows real dedication and passion for an important goal in science, to improve healthcare.

Which research discovery that you have made has made you most proud? 

I haven’t made any big discoveries so far, so I will safe this question for later in my PhD.

Given unlimited finance what experiment would you perform?

In the disease I am studying not only the amount of money but also the availability of patient material is limiting. Therefore I would want to invest in optimizing protocols to differentiate patient derived induced pluripotent stem cells to the different cell types which play a role in CDG and in developing organoids and organ-on-a-chip models to study tissues that are hard to gain access to, such as brain and heart

What does your working area (desk, office) look like and what does it say about you (or your research)?

It varies a lot. When I am very busy, running from one experiment to another, it can get a bit messy. Then at some point the mess starts to annoy me and I will tidy everything up at once.

Nominate a colleague to be in the spotlight and what would you like to ask him or her?

I would like to nominate Marieke Willemse and I would like to ask her what her favourite cell type is to look at under the microscope.

What type of person are you, quick insights:

a) Mac or PC?                                : PC
b) Theater or cinema?                 : Cinema
c) Dine out or dine in?                 : Dine in
d) Ferrari or Fiat?                         : Fiat
e) Shopaholic or chocoholic?     : Chocoholic
f) Culture or Nature                     : Nature

Related news items

Radium 223-mediated zonal cytotoxicity of prostate cancer in bone

21 January 2019

In preclinical prostate carcinoma in the bone, Rad-223 eradicated effectively micro-tumors but macro-tumors persisted and expanded. The data point to application of Rad-223 in secondary prevention of early bone-metastatic disease and regimens co-targeting the tumor core.

read more

COPAL reveals remodeling of mitochondrial protein complexes in Barth syndrome

21 January 2019

Martijn Huijnen, theme Mitochondrial diseases, and colleagues developed COmplexome Profiling ALignment (COPAL) to systematically asses the effect of Barth syndome on mitochondrial protein complexes. They published their findings in Bioinformatics.

read more

Two papers on molecular mechanisms of GFI1B in inherited bleeding syndromes in Haematologica

21 January 2019

Rinske van Oorschot from the Van der Reijden group, theme Cancer development and immune defense, has published two papers on the transcription factor GFI1B in Haematologica.

read more

LEO Foundation grant for Ellen van den Bogaard and Patrick Zeeuwen

17 January 2019

LEO Foundation ‘Open competition grants’ are given to support the best dermatology research projects worldwide that improve the understanding of the underlying medicinal, biological, chemical, or pharmacological mechanisms of dermatological diseases and their symptoms.

read more

RIMLS awards festival Twelve winners

16 January 2019

In 5 categories RIMLS young researchers received an award and bonus during the New Year's drinks. See all photo's.

read more

RIMLS award for Bert van der Reijden

16 January 2019

Bert van der Reijden, theme Cancer development and immune defense, received the RIMLS award 2018 for his long-lasting and dedicated commitment to the RIMLS Graduate School.

read more
  • Go to